ArticleChemistry (Weinheim an der Bergstrasse, Germany)2020
Yield-not only Lifetime-of the Photoinduced Charge-Separated State in Iridium Complex-Polyoxometalate Dyads Impact Their Hydrogen Evolution Reactivity.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 28 citations in OpenAlex.
- Covalently linked ferrocene-polyoxometalate dyads for light-induced radical generation.Chemical science · 2026Article
- Unveiling photoinduced electron transfers in photosensitized polyoxometalates for solar energy conversion.Chemical science · 2025Review
- Covalent organic-inorganic polyoxometalate hybrids in catalysis.Frontiers in chemistry · 2024Review
- Better Covalent Connection in a Molecular Triad Enables More Efficient Photochemical Energy Storage.Inorganic chemistry · 2023Article
- Photophysics of Anionic Bis(4H-imidazolato)CuChemistry (Weinheim an der Bergstrasse, Germany) · 2022Article
- A photo-switchable molecular capsule: sequential photoinduced processes.Chemical science · 2022Article
- A photosensitizer-polyoxometalate dyad that enables the decoupling of light and dark reactions for delayed on-demand solar hydrogen production.Nature chemistry · 2022Article
- Multifunctional Polyoxometalate Platforms for Supramolecular Light-Driven Hydrogen Evolution*.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021Article
- Covalent Linkage of BODIPY-Photosensitizers to Anderson-Type Polyoxometalates Using CLICK Chemistry.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021Article
- Controlling Spin-Correlated Radical Pairs with Donor-Acceptor Dyads: A New Concept to Generate Reduced Metal Complexes for More Efficient Photocatalysis.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021Article
- A photoredox catalysed Heck reactionRSC advances · 2020Article
- Yield-not only Lifetime-of the Photoinduced Charge-Separated State in Iridium Complex-Polyoxometalate Dyads Impact Their Hydrogen Evolution Reactivity.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
Covalently linked photosensitizer-polyoxometalate (PS-POM) dyads are promising molecular systems for light-induced energy conversion processes, such as "solar" hydrogen generation. To date, very little is known of their fundamental photophysical properties which affect the catalytic reactivity and stability of the systems. PS-POM dyads often feature short-lived photoinduced charge-separated states, and the lifetimes of these states are considered crucial for the function of PS-POM dyads in molecular photocatalysis. Hence, strategies have been developed to extend the lifetimes of the photoinduced charge-separated states, either by tuning the PS photophysics or by tuning the POM redox properties. Recently, some of us reported PS-POM dyads based on cyclometalated Ir
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.